Ongoing 00403784-2026urn:tendersight:notices:types:eu-procurement:cn-standardurn:tendersight:notices:source-systems:eu:ted
Biologická léčba 2026 II
3 Lots
Total estimated value: 9.210.290 CZK
1
I. Everolimus (ATC L01EG02)
CPV: 33652100-6 - Antineoplazice
1.973.861 CZK
Estimated value
Offer deadline
13 iulie 2026 la 07:00
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
2
III. Denosumab (ATC M05BX04)
CPV: 33652100-6 - Antineoplazice
4.280.381 CZK
Estimated value
Offer deadline
13 iulie 2026 la 07:00
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
3
II. Axitinib (ATC L01EK01)
CPV: 33652100-6 - Antineoplazice
2.956.046 CZK
Estimated value
Offer deadline
13 iulie 2026 la 07:00
Quantity
1
Contract value
Not specified
Award criteria
0 criteria